Convatec Group Overview
- Year Founded
-
1978
- Status
-
Public
- Employees
-
10,000
- Stock Symbol
-
CTEC
- Investments
-
16
- Share Price
-
$3.53
- (As of Thursday Closing)
Convatec Group General Information
Description
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute care hospital and chronic care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
Contact Information
Website
www.convatecgroup.comCorporate Office
- 7th Floor
- 20 Eastbourne Terrace
- London W2 6LG
- England, United Kingdom
Corporate Office
- 7th Floor
- 20 Eastbourne Terrace
- London W2 6LG
- England, United Kingdom
Convatec Group Timeline
Convatec Group Stock Performance
As of 19-Nov-2026, Convatec Group’s stock price is $3.53. Its current market cap is $6.73B with 1.91B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.53 | $3.57 | $2.60 - $3.60 | $6.73B | 1.91B | 8.34M | $0.06 |
Convatec Group Financials Summary
As of 30-Jun-2026, Convatec Group has a trailing 12-month revenue of $2.49B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,996,059 | 7,605,361 | 6,982,882 | 7,774,834 |
| Revenue | 2,491,000 | 2,439,000 | 2,289,000 | 2,142,400 |
| EBITDA | 449,000 | 513,000 | 536,000 | 450,300 |
| Net Income | 124,000 | 175,000 | 191,000 | 130,300 |
| Total Assets | 3,786,000 | 3,781,000 | 3,515,000 | 3,713,700 |
| Total Debt | 1,741,000 | 1,518,000 | 1,202,000 | 1,312,400 |
Convatec Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Convatec Group Comparisons
Industry
Financing
Details
Convatec Group Competitors (9)
One of Convatec Group’s 9 competitors is Zimmer Biomet Holdings, a Corporation company based in Warsaw, IN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| Orchid Orthopedic Solutions | Private Equity-Backed | Mason, MI | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Joerns Healthcare | Private Equity-Backed | Charlotte, NC |
Convatec Group Patents
Convatec Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025198867-A1 | Brachytherapy composition and related methods | Pending | 18-Mar-2024 | ||
| EP-4547171-A2 | Coupling system for ostomy appliances | Pending | 01-Jul-2022 | ||
| EP-4547171-A4 | Coupling system for ostomy appliances | Pending | 01-Jul-2022 | ||
| US-20250213384-A1 | Coupling system for ostomy appliances | Pending | 01-Jul-2022 | ||
| WO-2024006836-A2 | Coupling system for ostomy appliances | Inactive | 01-Jul-2022 | A61F5/443 |
Convatec Group Signals
Convatec Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Convatec Group Investments & Acquisitions (16)
Convatec Group’s most recent deal was a Merger/Acquisition with Livramedom for . The deal was made on 17-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Livramedom | 17-Sep-2024 | Merger/Acquisition | Elder and Disabled Care | ||
| Starlight Science | 18-Apr-2023 | Merger/Acquisition | Other Devices and Supplies | ||
| BlueWind Medical | 04-May-2022 | Later Stage VC | Therapeutic Devices | ||
| Triad Life Sciences | 24-Feb-2022 | Merger/Acquisition | Biotechnology | ||
| Patient Care Medical | 01-Dec-2021 | Merger/Acquisition | Distributors/Wholesale |
Convatec Group ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
10.51 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Supplies
Subindustry
of 60
Rank
Percentile
Convatec Group Exits (2)
Convatec Group’s most recent exit was on 01-Sep-2017 from Personally Delivered. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Personally Delivered | 01-Sep-2017 | Completed |
|
||
| Unora | 01-Jun-2012 | Buyout/LBO | Completed |
|
Convatec Group Affiliates
Subsidiaries (19)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Convatec Nap | Deeside, United Kingdom | 2023 | |
| Starlight Science | Deeside, United Kingdom | 2022 | |
| Patient Care Medical | Austin, TX | 2010 | |
| SureCalm Healthcare | Basingstoke, United Kingdom | 2010 | |
| AbViser Medical | Montgomery, NJ | 2010 |
Convatec Group FAQs
-
When was Convatec Group founded?
Convatec Group was founded in 1978.
-
Where is Convatec Group headquartered?
Convatec Group is headquartered in London, United Kingdom.
-
What is the size of Convatec Group?
Convatec Group has 10,000 total employees.
-
What industry is Convatec Group in?
Convatec Group’s primary industry is Therapeutic Devices.
-
Is Convatec Group a private or public company?
Convatec Group is a Public company.
-
What is Convatec Group’s stock symbol?
The ticker symbol for Convatec Group is CTEC.
-
What is the current stock price of Convatec Group?
As of 19-Nov-2026 the stock price of Convatec Group is $3.53.
-
What is the current market cap of Convatec Group?
The current market capitalization of Convatec Group is $6.73B.
-
What is Convatec Group’s current revenue?
The trailing twelve month revenue for Convatec Group is $2.49B.
-
Who are Convatec Group’s competitors?
Zimmer Biomet Holdings, Orchid Orthopedic Solutions, Medtronic, Globus Medical, and Joerns Healthcare are some of the 9 competitors of Convatec Group.
-
What is Convatec Group’s annual earnings per share (EPS)?
Convatec Group’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process